Evidence map›Paper›PMID 31547096›Full record

ArticleJournal of clinical medicine2019

Evaluation of Apelin and Apelin Receptor Level in the Primary Tumor and Serum of Colorectal Cancer Patients.

Marta Podgórska, Dorota Diakowska, Katarzyna Pietraszek-Gremplewicz, Miroslaw Nienartowicz, Dorota Nowak

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Apelin/APJ: Another Player in the Cancer Biology Network.International journal of molecular sciences · 2025
    Review
  2. Article
  3. Article
  4. The role of apelin in cancer.Frontiers in oncology · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Significance of Serum Apelin Levels as a Biomarker for Gastric Cancer Diagnosis.Asian Pacific journal of cancer prevention : APJCP · 2023
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Research advances of secretory proteins in malignant tumors.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2021
    Article
  14. Obesity and triple-negative-breast-cancer: Is apelin a new key target?Journal of cellular and molecular medicine · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Marta PodgórskaDepartment of Cell Pathology, Faculty of Biotechnology, University of Wroclaw, 50-383 Wroclaw, Poland. marta.podgorska2@uwr.edu.pl.
Dorota DiakowskaDepartment of Nervous System Diseases, Wroclaw Medical University, 51-618 Wroclaw, Poland. dorota.diakowska@umed.wroc.pl.ORCID 0000-0002-1377-5601
Katarzyna Pietraszek-GremplewiczDepartment of Cell Pathology, Faculty of Biotechnology, University of Wroclaw, 50-383 Wroclaw, Poland. katarzyna.pietraszek-gremplewicz@uwr.edu.pl.
Miroslaw NienartowiczDepartment of Gastrointestinal and General Surgery, Wroclaw Medical University, 50-368 Wroclaw, Poland. miroslaw.nienartowicz@umed.wroc.pl.
Dorota NowakDepartment of Cell Pathology, Faculty of Biotechnology, University of Wroclaw, 50-383 Wroclaw, Poland. dorota.nowak@uwr.edu.pl.
University of Wrocław · PLWroclaw Medical University · PL

Funding

Narodowe Centrum Nauki 2016/23/D/NZ5/00049
6 · The paper itself

Abstract

Colorectal cancer is the second deadliest tumor, which has a positive correlation with obesity which led to increasing interest in the relationship between adipokines and cancer progression. Apelin is a secreted peptide involved in regulation of tumor progression and invasiveness. In this study, we examined apelin and apelin receptor expression level in colorectal cancer. Apelin, and its receptor mRNA, and protein expression levels were measured in tumor tissue of 56 surgically treated colorectal adenocarcinoma (CRC) patients. We also analyzed apelin and apelin receptor protein levels in sera of 56 CRC patients and 27 healthy controls. The mRNA and protein level of this peptide and its receptor was higher in tumors than that in control tissue. Serum levels of apelin and apelin receptor were increased in CRC patients in comparison to controls. The concentration of serum apelin level significantly increased in individuals with lymph node and distant metastasis. Obtained results suggest that apelin could be an important factor in progression of colorectal carcinoma.

Indexed as

adipokinesapelinapelin receptorcolorectal cancer

Identifiers

PMID31547096
PMCPMC6832595
OpenAlexW2974842239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.